The FDA just unveiled its new, pricier fee schedule to review new drugs
With the new user fee deals signed into law, the FDA unveiled a new increased fee schedule that will apply to biopharmaceutical companies for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
